Skip to main content
. 2015 Apr 10;172(12):3141–3150. doi: 10.1111/bph.13116

Figure 2.

Figure 2

The effect of selected RTKIs on NFAT gene transcription stimulated by 1 nM VEGF165a. VEGFR2 NFAT cells were treated with (A) cediranib, (B) pazopanib, (C) vandetanib or (D) sorafenib. Data are mean ± SEM of five separate experiments. Data are expressed as a percentage of the response to 1 nM VEGF165a in the absence of RTKIs. Each individual experiment was performed in quadruplicate.